» Articles » PMID: 26160710

A Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein with Potential for the Treatment of Menopausal Syndrome

Overview
Journal Sci Rep
Specialty Science
Date 2015 Jul 11
PMID 26160710
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A novel protein, designated as DOI, isolated from the Chinese yam (Dioscorea opposita Thunb.) could be the first protein drug for the treatment of menopausal syndrome and an alternative to hormone replacement therapy (HRT), which is known to have undesirable side effects. DOI is an acid- and thermo-stable protein with a distinctive N-terminal sequence Gly-Ile-Gly-Lys-Ile-Thr-Thr-Tyr-Trp-Gly-Gln-Tyr-Ser-Asp-Glu-Pro-Ser-Leu-Thr-Glu. DOI was found to stimulate estradiol biosynthesis in rat ovarian granulosa cells; induce estradiol and progesterone secretion in 16- to 18-month-old female Sprague Dawley rats by upregulating expressions of follicle-stimulating hormone receptor and ovarian aromatase; counteract the progression of osteoporosis and augment bone mineral density; and improve cognitive functioning by upregulating protein expressions of brain-derived neurotrophic factor and TrkB receptors in the prefrontal cortex. Furthermore, DOI did not stimulate the proliferation of breast cancer and ovarian cancer cells, which suggest it could be a more efficacious and safer alternative to HRT.

Citing Articles

A new osteogenic protein isolated from Thunb accelerates bone defect healing through the mTOR signaling axis.

Kubi J, Brah A, Cheung K, Lee Y, Lee K, Sze S Bioact Mater. 2023; 27:429-446.

PMID: 37152710 PMC: 10160600. DOI: 10.1016/j.bioactmat.2023.04.018.


A combination containing natural extracts of clove, Sophora flower bud, and yam improves fertility in aged female mice multiple mechanisms.

Liu W, Wang X, Chen Y, Zhang H, Chen J, Zhang J Front Endocrinol (Lausanne). 2022; 13:945690.

PMID: 36483000 PMC: 9724743. DOI: 10.3389/fendo.2022.945690.


Baicalin regulates stem cells as a creative point in the treatment of climacteric syndrome.

Wei Q, Hao X, Lau B, Wang S, Li Y Front Pharmacol. 2022; 13:986436.

PMID: 36408261 PMC: 9666758. DOI: 10.3389/fphar.2022.986436.


Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.

Wang Y, Xie W, Hou M, Tian J, Zhang X, Ren Q Aging (Albany NY). 2021; 13(8):11026-11042.

PMID: 33647882 PMC: 8109108. DOI: 10.18632/aging.202641.


A Review of the Science of Colorful, Plant-Based Food and Practical Strategies for "Eating the Rainbow".

Minich D J Nutr Metab. 2021; 2019:2125070.

PMID: 33414957 PMC: 7770496. DOI: 10.1155/2019/2125070.


References
1.
Mascitelli L, Goldstein M . Menopause, estrogen, statins, and the immune system. Maturitas. 2010; 68(2):197. DOI: 10.1016/j.maturitas.2010.11.007. View

2.
Lowe G . Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease. J Intern Med. 2004; 256(5):361-74. DOI: 10.1111/j.1365-2796.2004.01400.x. View

3.
Depypere H, Hillard T, Erkkola R, Lukkari-Lax E, Kunz M, Rautiainen P . A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause. Eur J Obstet Gynecol Reprod Biol. 2010; 153(2):176-80. DOI: 10.1016/j.ejogrb.2010.08.017. View

4.
Lampio L, Polo-Kantola P, Polo O, Kauko T, Aittokallio J, Saaresranta T . Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms. Menopause. 2014; 21(11):1217-24. DOI: 10.1097/GME.0000000000000239. View

5.
Buist D, Newton K, Miglioretti D, Beverly K, Connelly M, Andrade S . Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004; 104(5 Pt 1):1042-50. DOI: 10.1097/01.AOG.0000143826.38439.af. View